Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

CVC “frontrunner to buy Eugin”

HBI hears that CVC is frontrunner to buy international IVF chain Eugin as parent company NMC Health's administrators Alvarez and Marsal looks to complete a lender-led sale of the group by Spring 2021.

Quarterly sales performance across Europe’s subsectors

As we head into the fourth quarter of the financial year, the impact of the COVID-19 pandemic on organic and inorganic growth is becoming clearer. Most groups have tipped back into positive growth but the lockdowns that hit finances so hard in the first half of the year are either looming or in full swing already.

Artemis “enters sales process”

Artemis, Germany's second largest ophthalmology chain by revenue, has entered a sales process, HBI hears from multiple sources.

Europe’s largest specialist leukaemia lab on sale for €480m

Munich Leukaemia Laboratory (MLL), a specialist founder-owned lab in Germany, is for sale with a potential €480m price tag. A source says it's one of the "most modern genetics labs" in the world and is likely to sell to one of the large lab groups.

Manipal buys Columbia Asia in India

As predicted by HBI, India-based multi-speciality healthcare provider Manipal Hospitals has agreed to acquire 100% of Columbia Asia's Indian hospitals from Columbia Pacific Management. The deal is valued at Rs 2,100 crore ($282m) including debt.

Find Us